Literature DB >> 28188080

The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease.

Petra Tomše1, Luka Jensterle2, Sebastijan Rep3, Marko Grmek4, Katja Zaletel5, David Eidelberg6, Vijay Dhawan7, Yilong Ma8, Maja Trošt9.   

Abstract

PURPOSE: To evaluate the reproducibility of the expression of Parkinson's Disease Related Pattern (PDRP) across multiple sets of 18F-FDG-PET brain images reconstructed with different reconstruction algorithms.
METHODS: 18F-FDG-PET brain imaging was performed in two independent cohorts of Parkinson's disease (PD) patients and normal controls (NC). Slovenian cohort (20 PD patients, 20 NC) was scanned with Siemens Biograph mCT camera and reconstructed using FBP, FBP+TOF, OSEM, OSEM+TOF, OSEM+PSF and OSEM+PSF+TOF. American Cohort (20 PD patients, 7 NC) was scanned with GE Advance camera and reconstructed using 3DRP, FORE-FBP and FORE-Iterative. Expressions of two previously-validated PDRP patterns (PDRP-Slovenia and PDRP-USA) were calculated. We compared the ability of PDRP to discriminate PD patients from NC, differences and correlation between the corresponding subject scores and ROC analysis results across the different reconstruction algorithms.
RESULTS: The expression of PDRP-Slovenia and PDRP-USA networks was significantly elevated in PD patients compared to NC (p<0.0001), regardless of reconstruction algorithms. PDRP expression strongly correlated between all studied algorithms and the reference algorithm (r⩾0.993, p<0.0001). Average differences in the PDRP expression among different algorithms varied within 0.73 and 0.08 of the reference value for PDRP-Slovenia and PDRP-USA, respectively. ROC analysis confirmed high similarity in sensitivity, specificity and AUC among all studied reconstruction algorithms.
CONCLUSIONS: These results show that the expression of PDRP is reproducible across a variety of reconstruction algorithms of 18F-FDG-PET brain images. PDRP is capable of providing a robust metabolic biomarker of PD for multicenter 18F-FDG-PET images acquired in the context of differential diagnosis or clinical trials.
Copyright © 2017 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FDG-PET; Parkinson’s disease; Reconstruction algorithms; Specific metabolic brain networks

Mesh:

Substances:

Year:  2017        PMID: 28188080      PMCID: PMC5547017          DOI: 10.1016/j.ejmp.2017.01.018

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  20 in total

1.  Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging.

Authors:  Carole Lartizien; Paul E Kinahan; Richard Swensson; Claude Comtat; Michael Lin; Victor Villemagne; Régine Trébossen
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

2.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

Review 3.  Focus on time-of-flight PET: the benefits of improved time resolution.

Authors:  Maurizio Conti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-13       Impact factor: 9.236

4.  Exact and approximate rebinning algorithms for 3-D PET data.

Authors:  M Defrise; P E Kinahan; D W Townsend; C Michel; M Sibomana; D F Newport
Journal:  IEEE Trans Med Imaging       Date:  1997-04       Impact factor: 10.048

5.  Performance characteristics of a whole-body PET scanner.

Authors:  T R DeGrado; T G Turkington; J J Williams; C W Stearns; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1994-08       Impact factor: 10.057

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

9.  Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.

Authors:  Ping Wu; Jian Wang; Shichun Peng; Yilong Ma; Huiwei Zhang; Yihui Guan; Chuantao Zuo
Journal:  Parkinsonism Relat Disord       Date:  2013-03-23       Impact factor: 4.891

10.  Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data.

Authors:  J R Moeller; S C Strother; J J Sidtis; D A Rottenberg
Journal:  J Cereb Blood Flow Metab       Date:  1987-10       Impact factor: 6.200

View more
  9 in total

1.  Identification and validation of Alzheimer's disease-related metabolic brain pattern in biomarker confirmed Alzheimer's dementia patients.

Authors:  Matej Perovnik; Petra Tomše; Jan Jamšek; Andreja Emeršič; Chris Tang; David Eidelberg; Maja Trošt
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

2.  Validation of abnormal glucose metabolism associated with Parkinson's disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging.

Authors:  Rongbing Jin; Jingjie Ge; Ping Wu; Jiaying Lu; Huiwei Zhang; Jian Wang; Jianjun Wu; Xianhua Han; Weishan Zhang; Chuantao Zuo
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-06       Impact factor: 2.570

3.  Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT).

Authors:  Rosalie V Kogan; Bas A de Jong; Remco J Renken; Sanne K Meles; Paul J H van Snick; Sandeep Golla; Sjoerd Rijnsdorp; Daniela Perani; Klaus L Leenders; Ronald Boellaard
Journal:  Alzheimers Dement (Amst)       Date:  2019-06-22

4.  Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.

Authors:  Sanne K Meles; Remco J Renken; Marco Pagani; L K Teune; Dario Arnaldi; Silvia Morbelli; Flavio Nobili; Teus van Laar; Jose A Obeso; Maria C Rodríguez-Oroz; Klaus L Leenders
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-25       Impact factor: 9.236

5.  Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy.

Authors:  Ping Zhao; Benshu Zhang; Shuo Gao; Xin Li
Journal:  Brain Behav       Date:  2020-09-17       Impact factor: 2.708

6.  A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science.

Authors:  Xiao-Ling Li; Rui-Xue Gao; Qinhong Zhang; Ang Li; Li-Na Cai; Wei-Wei Zhao; Sheng-Lan Gao; Yang Wang; Jinhuan Yue
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

7.  Use of radiomic features and support vector machine to distinguish Parkinson's disease cases from normal controls.

Authors:  Yue Wu; Jie-Hui Jiang; Li Chen; Jia-Ying Lu; Jing-Jie Ge; Feng-Tao Liu; Jin-Tai Yu; Wei Lin; Chuan-Tao Zuo; Jian Wang
Journal:  Ann Transl Med       Date:  2019-12

8.  FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.

Authors:  Dawn C Matthews; Hedva Lerman; Ana Lukic; Randolph D Andrews; Anat Mirelman; Miles N Wernick; Nir Giladi; Stephen C Strother; Karleyton C Evans; Jesse M Cedarbaum; Einat Even-Sapir
Journal:  Neuroimage Clin       Date:  2018-08-10       Impact factor: 4.881

9.  Positron emission tomography/computed tomography dual imaging using 18-fluorine flurodeoxyglucose and 11C-labeled 2-β-carbomethoxy-3-β-(4-fluorophenyl) tropane for the severity assessment of Parkinson disease.

Authors:  Xiaohong Li; Qizhou Zhang; Yongde Qin; Yubin Li; Nazimuguli Mutaerbieke; Xiaojia Zhao; Amina Yibulayin
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.